2020
- Sami-Sabinsa Group to Set Up New Manufacturing Facility in Hassan, Karnataka at an Investment of Rs. 200 Crore
- Sabinsa’s Curcumin C3 Complex® With BioPerine® Shown To Improve Cytokine Levels
- Dr. Majeed Foundation Makes Significant Contributions to Combat COVID-19 in India, Including $1.32 Million to PM CARES Fund
- Sabinsa Warns Industry Against Mischaracterized Amla Extracts
- Research Review of Curcumin’s Immune Benefits by Sabinsa Founder Dr. Muhammed Majeed Published
- Sabinsa's pTeroWhite® Subject of Two New Published Studies Reporting Anti-Aging, Skin Brightening, and SPF Benefits
- Sami-Sabinsa Group to Set Up New Manufacturing Facility in Hassan, Karnataka at an Investment of Rs. 200 Crore
- Sabinsa’s Parent Company Sami Labs Breaks Ground on $30 Million USD State-of-the-Art Production Facility in India
- Sami-Sabinsa Group Celebrates Three Prestigious Awards From ASSOCHAM
2019
- Sabinsa Opens Sales Office in Poland to Serve Eastern Europe
- Sabinsa Named a Top New Jersey Company for Its Dynamic Growth
- Sabinsa Issued New U.S. Patent for LactoSpore® Based upon Published Research Confirming Ability to Reverse Depression Symptoms in Patients Suffering from IBS
- Sabinsa’s Pterostilbene in Silbinol® Subject of Published Study
- Sabinsa’s Parent Dubbed Most Trusted Nutraceutical Company
- Government of Karnataka State, India Recognizes the Sami- Sabinsa Group with Three Awards for Export Excellence
- Research Finds Sabinsa’s Curcumin C3 Complex® in Combination with BioPerine® Effective for Non-Alcoholic Fatty Liver Disease
- Sami-Sabinsa Honored with Multiple “Best of” Awards in New Delhi and Singapore
- Sabinsa Founder Dr. Muhammed Majeed Publishes Book on Reductive Metabolites of Curcuminoids
- Sabinsa to Feature Tinofolin® Nootropic, Livinol™ for Liver Health & Weight Control, and Starmeric™ Turmeric-Derived Prebiotic at Supplyside West
- Sabinsa’s Four Indian Manufacturing Sites Achieve FSSC 22000 Certification
- New Research Expands upon Use of Sabinsa’s Curcumin C3 Complex® as an Adjunct to Chemotherapy
- Sabinsa’s Curcumin C3 Reduct® Self-Affirmed GRAS
- Sabinsa Achieves USP GMP Audited Status for Three Additional Sites
- Published Study Reaffirms Function and Survival of Sabinsa’s LactoSpore®
- Sabinsa Shagandha™ Ashwagandha Root Extract 2.5% Designed to Meet USP Monograph, Verified by Prominent Botanical Testing Expert Alkemist Labs
- Sabinsa Scientist Dr. Natarajan honored by IASTAM for Nutraceutical Product Development
- Sabinsa Launches LactoSporin®: Novel Probiotic Metabolite For Skin and Hair
- Sabinsa Awarded New Patents for ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
- Sabinsa’s Biotechnology Site Achieves USP GMP Audited Status
- Sabinsa’s Manufacturing Arm Receives Research Funding From The Government of India
- Published Analysis of Curcumin Research Provides Comprehensive Overview
2018
- Sami-Sabinsa group acquires Exclusive Global Marketing Rights for European and USA Patents on Oroxylum indicum
- Sami Labs - Sabinsa Hyderabad facility receives NSF GMP certification
- Sami-Sabinsa recognized for Export Achievement by Federation of Karnataka Chambers of Commerce & Industry
- Sami-Sabinsa’s Pterocarpus Marsupium reforestation program named Industry Initiative of the Year Award Finalist
- Sami-Sabinsa group acquires Exclusive Global Marketing Rights for European and USA Patents on Oroxylum indicum
- Sami-Sabinsa group scientists publish research on Flow Cytometry as an effective test method to assess viable spore count in LactoSpore®
- Sami–Sabinsa Founder and Sami Labs Honored with multiple awards by Associated Chambers of Commerce & Industry of India for Outstanding Nutraceuticals Industry Achievement
- Sami-Sabinsa honored by Pharmexcil for Export Excellence
- Sami–Sabinsa honored by Associated Chambers of Commerce & Industry of India for Beauty, Wellness & Personal Care
- Sami-Sabinsa group FSMA Implementation Update: 14 Staff PCQI Certified
2017
- Shaheen Majeed named Sabinsa President worldwide
- Sami Labs publishes scientific compendium on BioPerine® black pepper extract
- Shaheen Majeed named Sabinsa President worldwide
- Sami Lab’s Curcumin C3 Complex® with BioPerine® shows protective role in lipid profile modification in type 2 diabetes in published study
2016
- Dr. Majeed, Sabinsa’s founder, honored with Global Innovation & Excellence Award for 110 patents
- Sami Labs’S Boswellin® super reported in Japanese study to show improvement in knee pain
- European journal publishes article on Sami Labs oil control moisturizer safety and efficacy
- Sami Labs’s Curcumin C3 Complex® in combination with Omega-3S found to have synergistic effect
- Sami Labs honored with two pharmexcil awards noting excellence in patents and exports
- Sami Labs recognized by global health & pharma as the best international life science company and most innovative inflammatory condition treatment
- Sami Labs recognized for excellence in research and development
- Sami Labs recognized for export excellence by Karnataka government trade promotion center
- Muhammed Majeed, Ph.D. honored as industry legend and inducted into the Hall of Legends at Natural Products Expo West, 2016
- Dr. Majeed, Sabinsa’s founder, honored with Global Innovation & Excellence Award for 110 patents
2015
- Shaheen Majeed appointed to Sami Labs group board of directors
- Sami Labs patent infringement litigation against prakruti settled: Curcumin C3 Complex® patent successfully defended
- Sami Labs launches new, nano-free water soluble curcumin form: Uc3 clearTM
- Sami Labs recognized with two state export excellence awards by visvesvaraya trade promotion centre, Karnataka, India
- Sami Labs once more successfully protects Curcumin C3 Complex® patent infringement litigation against herbakraft settled
- Sami Labs expands herb cultivation program founder promotes sustainability, advocates cultivation to protect India’s herbal legacy
- Sami Lab’s Curcumin C3 Complex® shows significant benefits in lipid levels in patients with coronary artery disease
- UK study shows Sami Lab’s Curcumin C3 Complex® to be safe adjunct to, and enhance efficacy of, folfox chemotherapy
- Sami Lab recognized with award for export excellence by Karnataka chamber of commerce
- Shaheen Majeed appointed to Sami Labs group board of directors
- Sami Labs honored with two pharmexcil awards noting excellence in patents and exports
- Curry Powder To Clinical Significance: New book provides a comprehensive understanding of curcumin & studies on Curcumin C3 Complex®
2014
- Former President of India, Dr. A.P.J. Abdul Kalam visits Sami Labs
- Sami Labs adds four new patents, bringing worldwide portfolio to 91
- C3 Reduct® wins Functional Ingredients editors choice award for best science
- Sami Labs receiveS Best New Product Excellence Award in the raw material category at Panacea-Natural Product Expo India for Saberry®
- Sami Labs entered into a Memorandum of Understanding with India’s Ayurvedic research organization, Arya Vaidya Sala, Kottakkal (AVS)
- Sami Labs receives two Pharmexcil awards for 2012 – 2013 in the herbals, ayurveda & nutraceuticals category: The gold award for patents and the silver award for exports in herbals
- Former President of India, Dr. A.P.J. Abdul Kalam visits Sami Labs
- Sami Labs introduces new form of coleus with ForsLean® Soft Extract
- Study shows Boswellia® cream may provide relief for psoriasis
- Sami Labs initiates lawsuit against four companies for Curcumin C3 Complex® patent infringement
- Sami Lab’s C3 Complex® shown in study to benefit metabolic syndrome
- Sami Labs acquires KCP Biotech, expands capacity and adds more colors
2013
2012
- Sami Labs wins patent in Japan for coleus derived Glaucoma Treatment product
- Curcumin C3 Complex® wins Functional Ingredients editor's choice award in the marketing category
- New Study says Sami Labs's Curcumin C3 Complex® shows significant reduction in Serum Triglycerides
- Sami Labs publishes book on Tetrahydrocurcuminoids
- Sami Labs wins patent in Japan for coleus derived Glaucoma Treatment product
2011
2010
- Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian Market
- Received the first Patent in China for “Process For Preparing Water Soluble Diterpenes And Their Applications
- Sami Labs inks an agreement with CIPLA to market its drug, Sornip for Psoriasis in Indian Market
- Sami’s Kunigal plant near Bangalore, India received Bureau Veritas ISO 22000 Certification
2009
2008
- Sabinsa receives NBJ Supplement Ingredient Product Merit Award for Curcumin C3 Complex®
- DCGI approves Sami Labs’s natural drug for Psoriasis
- NABL accreditation for Laboratories of Sami Labs
- Continuous Extraction plant Started at Dobaspet, Karnataka
- Sabinsa receives NBJ Supplement Ingredient Product Merit Award for Curcumin C3 Complex®
2006
- Received 16th & 17th US Patent
- Sami Labs receives the DCGI approval to manufacture and market Ocufors(1% Forskolin - Approval No.MF-6746/06), a natural drug for treating Glaucoma
- Awarded a product merit award by Nutrition Business Journal (NBJ) for the brand L- (+) Selenomethionine compound, Selenium SeLECT®, and an Investment in Science and Research award for ForsLean®
- Received the 17th US Patent (US Patent # 6,99,8502) for the “A Convenient Process Of Manufacture For Difluromethylornithine and Related Compounds"
- Received the 16th US Patent (US Patent # 6,982,273) for the “Composition and methods containing bioavailable Se-methyl-L-Selenochysteine for human and veterinary use"
2005
- Sabinsa's US Patent (No 6,849,645 ) for Tetrahydropiperine received Thomas Alva Edison Patent Award for 2005
- Received the 4th European Patent (EP1341547) for the “Method of increased nutritional and cosmetic compositions containing active ingredients from the liquid endosperm of fresh green coconuts, and a method for obtaining the active ingredients
- Sabinsa's US Patent (No 6,849,645 ) for Tetrahydropiperine received Thomas Alva Edison Patent Award for 2005
- Received the 14th US Patent (US Patent #6,849,645) for the “Method of increasedbioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and analogues and derivatives”
- Inaguaration of the new manufacturing facility at Kunigal, Karnataka
- Sami Labs felicitated its outstanding Coleus cultivators at a function held at Attur in Salem on 18th June
- Received the 3rd European Patent (EP0977564) for Forskolin for promoting Lean Body Mass, shifting the proportion of mass in favor of lean body mass, reducing fat tissue and encouraging weight loss
- Granted UK patent (GB 2380675) for “Method of increased bioavailability of nutrients and pharmaceutical preparation with tetrahydropiperine and its analogues and derivatives”
2004
- Sabinsa's US Patent (No5,804,596 ) for ForsLean® received the Thomas Alva Edison Patent Award for 2004
- Sabinsa's US Patent (No5 ,804,596 ) for ForsLean® received the Thomas Alva Edison Patent Award for 2004
- US patent #6,689,400 was issued for process of obtaining compositions of stable lutein and lutein derivatives
- US patent #6,794,537 was issued for manufacturing process for Se- Methyl-L-Selenocysteine
2003
- GarliSelect was introduced into the market
- GarliSelect was introduced into the market
- Mumbai office opened for marketing and co-ordination of clinical research
- Cosmeceutical dosage forms developed for marketing - Johara™ Line of Cosmeceuticals were born
- US patent #6,607,712 was issued for Coleus Forskohlii oil for antimicrobial properties
- US patent #6,653,327 was issued for Tetrahydrocurcuminoids
- MGP Herbal (P) Ltd was acquired by Sami Labs for fast tracking HerbalCultivation
2002
2001
- The anti-obesity product Forslean® was voted as the best product of the year by Nutraceutical Industry Association
- The anti-obesity product Forslean® was voted as the best product of the year by Nutraceutical Industry Association – Nutracon in the US
- European patent issued on Bioprotectant composition, method of use and extraction process of Curcuminoids
- Office opened in Japan for marketing
2000
1998
1997
- Sabinsa listed again in the Inc 500 companies, ranking # 90
- New Jersey Technology Fast 50 Award
- Sabinsa listed again in the Inc 500 companies, ranking # 90
- Award for Export Performance for Spice products from President of India
- Dr Raj Bammi joins as Director & President, Sami Labs. Dr Bammi holds MSand Ph.D from the University of California, California and has more than 25 years of experience with a major pharma group
